1. Khatami A, Pollard AJ. The epidemiology of meningococcal disease and the impact of vaccines. Expert Rev Vaccines. 2010; 9:285–298.
Article
3. Kang JH, Miao Y, Lee SY, Kim JH, Lee KY, Ma SH, Jo DS, Song HY, Haag M. A survey of serum bactericidal antibodies against Neisseria meningitidis serogroups A, C, W and Y in adolescents and adults in the Republic of Korea. Infect Chemother. 2016; 48:12–19.
Article
4. Caugant DA, Tzanakaki G, Kriz P. Lessons from meningococcal carriage studies. FEMS Microbiol Rev. 2007; 31:52–63.
Article
5. Durey A, Bae SM, Lee HJ, Nah SY, Kim M, Baek JH, Kang YH, Chung MH, Lee JS. Carriage rates and serogroups of Neisseria meningitidis among freshmen in a University dormitory in Korea. Yonsei Med J. 2012; 53:742–747.
Article
6. Hwang IU, Lee HK, Seo MY, Kim JP, Seo YB, Bang YJ. The changes of Meningococcal carriage rate and the serogroup in Korean army recruits. J Korean Mil Med Assoc. 2010; 41:188–199.
7. Jo YM, Bae SM, Kang YH. Cluster of serogroup W-135 meningococcal disease in 3 military recruits. J Korean Med Sci. 2015; 30:662–665.
Article
8. Abad R, López EL, Debbag R, Vazquez JA. Serogroup W meningococcal disease: global spread and current affect on the Southern Cone in Latin America. Epidemiol Infect. 2014; 142:2461–2470.
Article
9. Vyse A, Wolter JM, Chen J, Ng T, Soriano-Gabarro M. Meningococcal disease in Asia: an under-recognized public health burden. Epidemiol Infect. 2011; 139:967–985.
Article
10. Kim SA, Kim DW, Dong BQ, Kim JS, Anh DD, Kilgore PE. An expanded age range for meningococcal meningitis: molecular diagnostic evidence from population-based surveillance in Asia. BMC Infect Dis. 2012; 12:310.
Article
11. Goldschneider I, Gotschlich EC, Artenstein MS. Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med. 1969; 129:1307–1326.
12. Alberer M, Burchard G, Jelinek T, Reisinger EC, Meyer S, Forleo-Neto E, Dagnew AF, Arora AK. Immunogenicity and safety of concomitant administration of a combined hepatitis A/B vaccine and a quadrivalent meningococcal conjugate vaccine in healthy adults. J Travel Med. 2015; 22:105–114.
Article
13. Schrauder A, Claus H, Elias J, Vogel U, Haas W, Hellenbrand W. Capture-recapture analysis to estimate the incidence of invasive meningococcal disease in Germany, 2003. Epidemiol Infect. 2007; 135:657–664.
Article